Uncategorized

UK peptide suppliers serve laboratories working across an unusually wide range of synthetic peptides, from growth hormone secretagogues to GLP-1 receptor agonists to tissue-repair compounds, all sold under the same "research use only" designation but differing enormously in their chemistry, mechanism and evidence base. Because this category spans so many distinct compounds rather than one…

Researchers who buy peptides for laboratory use are not purchasing a single, uniform product category; they are sourcing synthetic compounds that differ enormously in sequence length, chemical modification and intended research application, while being expected to meet a common standard of documented identity and purity regardless of which specific peptide is involved. The practical question…

Buying peptides in the UK is not just a purchasing decision; it is the start of a logistics and storage chain that determines whether the material a laboratory receives still matches the specification it was ordered against. Lyophilised peptides are chemically stable in principle, but that stability depends on specific conditions being maintained between synthesis…

What are peptides? They are short chains of amino acids joined by peptide (amide) bonds, conventionally containing between two and roughly fifty residues and with molecular weights below about 5 kDa. They differ from proteins mainly in size and in the extent of stable tertiary folding. In the laboratory, peptides are used as receptor ligands,…

Research peptides UK laboratories use are synthetic amino acid chains, typically between two and fifty residues long, made by chemical synthesis and supplied as lyophilised powders for in-vitro work. They are used as receptor ligands, enzyme substrates, antigens, analytical standards and structural probes. Their value as tools depends entirely on verified identity, purity and correct…

PEG MGF is a PEGylated (polyethylene glycol-modified) form of the mechano growth factor (MGF) E-peptide, the 24-amino-acid C-terminal domain unique to the Ec splice variant of insulin-like growth factor 1 (IGF-1Ec). It is studied in the context of skeletal muscle satellite cell biology, since the native, unmodified MGF E-peptide has been reported to activate satellite…

ACE 031 is a recombinant fusion protein combining the extracellular, ligand-binding domain of the activin receptor type IIB (ActRIIB) with the Fc portion of human immunoglobulin G. It is studied as a "ligand trap" that binds and neutralises myostatin and activin A before these naturally occurring proteins can engage their membrane-bound receptors on skeletal muscle,…

GDF 8, more widely known as myostatin, is a member of the transforming growth factor-beta (TGF-β) superfamily that acts as a potent negative regulator of skeletal muscle mass. It is studied as the principal signalling ligand behind an entire field of muscle biology research, since mice, cattle and other species carrying loss-of-function mutations in the…

HGH fragments refers to synthetic peptides corresponding to the C-terminal region of human growth hormone, roughly residues 176 to 191, studied for a lipolytic (fat-mobilising) effect reported to be separable from growth hormone's classical growth-promoting and diabetogenic actions. The best-characterised member of this family is AOD9604, a modified version of the fragment carrying an additional…

GHRP 2, or growth hormone-releasing peptide-2, is a synthetic hexapeptide that acts as a full agonist at the growth hormone secretagogue receptor, GHS-R1a, the same receptor bound by the endogenous hormone ghrelin. It is studied for its stimulatory effect on pituitary growth hormone release and is widely used as a second-generation reference compound within the…

Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone (GHRH), comprising the complete 44-amino-acid GHRH(1-44) sequence with a trans-3-hexenoic acid group attached at the N-terminus. It is studied as a stimulator of endogenous, pulsatile growth hormone release from the anterior pituitary, acting through the GHRH receptor, and it is distinguished within the GHRH analogue…

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular methylation and NAD+ metabolism. It is not a peptide, despite often appearing alongside peptides in research-chemical catalogues; it is a methylquinolinium compound developed through medicinal chemistry rather than solid-phase peptide synthesis. In the laboratory it is studied chiefly in…